These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33728295)

  • 1. Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.
    Zhang XN; Wu LJ; Kong X; Zheng BY; Zhang Z; He ZW
    World J Clin Cases; 2021 Mar; 9(7):1513-1523. PubMed ID: 33728295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
    Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
    J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
    Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
    J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of COVID-19, SARS and MERS.
    Hu T; Liu Y; Zhao M; Zhuang Q; Xu L; He Q
    PeerJ; 2020; 8():e9725. PubMed ID: 32879801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.
    Wang Z; Yang B; Li Q; Wen L; Zhang R
    Clin Infect Dis; 2020 Jul; 71(15):769-777. PubMed ID: 32176772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How COVID-19 induces cytokine storm with high mortality.
    Hojyo S; Uchida M; Tanaka K; Hasebe R; Tanaka Y; Murakami M; Hirano T
    Inflamm Regen; 2020; 40():37. PubMed ID: 33014208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Coronavirus Pandemic: What Does the Evidence Show?
    Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O
    J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.
    Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new era for nuclear medicine.
    Chatzipavlidou V
    Hell J Nucl Med; 2020; 23(1):2-3. PubMed ID: 32361714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COVID-19 pandemic.
    Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
    Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease.
    Gurala D; Al Moussawi H; Philipose J; Abergel JR
    Cureus; 2020 Aug; 12(8):e10045. PubMed ID: 32983735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.
    Lauxmann MA; Santucci NE; Autrán-Gómez AM
    Int Braz J Urol; 2020 Jul; 46(suppl.1):6-18. PubMed ID: 32549071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.